Qinggang Xu

Years Active: 2020-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Feng Yu, Yang Gao, Yan Wu, Anran Dai, Xiaoyan Wang, Xiangzhi Zhang, Guodong Liu, Qinggang Xu, Dongfeng Chen
Combination of a Novel Fusion Protein CD3εζ28 and Bispecific T Cell Engager Enhances the Persistance and Anti-Cancer Effects of T Cells. Cancers 14 (19) (2022)
Xianggang Shi, Dongfeng Chen, Guodong Liu, Hailing Zhang, Xiaoyan Wang, Zhi Wu, Yan Wu, Feng Yu, Qinggang Xu
Application of Elastin-like Polypeptide in Tumor Therapy. Cancers 14 (15) (2022)
Feng Yu, Xiaoyan Wang, Hui Shi, Maorong Jiang, Jun Xu, Min Sun, Qinggang Xu, Frank Peprah Addai, Haifeng Shi, Jie Gu, Yang Zhou, Liqiong Liu
Development of chimeric antigen receptor-modified T cells for the treatment of esophageal cancer. Tumori 107 (4) (2020)

Qinggang Xu.css-eqlu8i{font-size:small;padding-left:4px;}